Localization and Targeting of the Saccharomyces Cerevisiae Kre2p/Mnt1p Alpha 1,2-mannosyltransferase to a Medial-Golgi Compartment
Overview
Affiliations
The yeast Kre2p/Mnt1p alpha 1,2-mannosyltransferase is a type II membrane protein with a short cytoplasmic amino terminus, a membrane-spanning region, and a large catalytic luminal domain containing one N-glycosylation site. Anti-Kre2p/Mnt1p antibodies identify a 60-kD integral membrane protein that is progressively N-glycosylated in an MNN1-dependent manner. Kre2p/Mnt1p is localized in a Golgi compartment that overlaps with that containing the medial-Golgi mannosyltransferase Mnn1p, and distinct from that including the late Golgi protein Kex1p. To determine which regions of Kre2p/Mnt1p are required for Golgi localization, Kre2p/Mnt1p mutant proteins were assembled by substitution of Kre2p domains with equivalent sequences from the vacuolar proteins DPAP B and Pho8p. Chimeric proteins were tested for correct topology, in vitro and in vivo activity, and were localized intracellularly by indirect immunofluorescence. The results demonstrate that the NH2-terminal cytoplasmic domain is necessary for correct Kre2p Golgi localization whereas, the membrane-spanning and stem domains are dispensable. However, in a test of targeting sufficiency, the presence of the entire Kre2p cytoplasmic tail, plus the transmembrane domain and a 36-amino acid residue luminal stem region was required to localize a Pho8p reporter protein to the yeast Golgi.
Schiavone M, Dagkesamanskaya A, Vieu P, Duperray M, Duplan-Eche V, Francois J Sci Rep. 2024; 14(1):20935.
PMID: 39251857 PMC: 11385505. DOI: 10.1038/s41598-024-72030-w.
Distinct adaptor proteins assist exit of Kre2-family proteins from the yeast ER.
Noda Y, Hara T, Ishii M, Yoda K Biol Open. 2014; 3(3):209-24.
PMID: 24585773 PMC: 4001239. DOI: 10.1242/bio.20146312.
Mechanisms of protein retention in the Golgi.
Banfield D Cold Spring Harb Perspect Biol. 2011; 3(8):a005264.
PMID: 21525512 PMC: 3140682. DOI: 10.1101/cshperspect.a005264.
Comparative genomics allowed the identification of drug targets against human fungal pathogens.
R Abadio A, Kioshima E, Teixeira M, Martins N, Maigret B, Felipe M BMC Genomics. 2011; 12:75.
PMID: 21272313 PMC: 3042012. DOI: 10.1186/1471-2164-12-75.
Dos Reis Almeida F, Oliveira L, de Sousa M, Roque Barreira M, Hanna E Yeast. 2009; 27(2):67-76.
PMID: 19908201 PMC: 3139792. DOI: 10.1002/yea.1731.